首页 | 本学科首页   官方微博 | 高级检索  
     

组织芯片技术研究食管胃黏膜病变中Ki-67的表达及其与细胞增殖和凋亡的关系
引用本文:常英,刘贵生,龚均,张军. 组织芯片技术研究食管胃黏膜病变中Ki-67的表达及其与细胞增殖和凋亡的关系[J]. 胃肠病学, 2009, 14(2): 103-106
作者姓名:常英  刘贵生  龚均  张军
作者单位:1. 上海交通大学附属第六人民医院消化内镜室,200233
2. 陕西省人民医院消化科
3. 西安交通大学医学院第二附属医院消化科
摘    要:背景:近20年来食管和食管胃连接处(EGJ)腺癌发生率呈上升趋势,Barrett食管(BE)被认为是其发生的重要危险因素。目的:应用组织芯片技术研究Ki-67在各类食管胃黏膜病变中的表达及其与细胞增殖和凋亡的关系。方法:制作140例各类食管胃黏膜组织的组织芯片,结合免疫组化方法检测Ki-67和增殖细胞核抗原(PCNA)表达。以原位末端标记技术(TUNEL法)检测BE、食管腺癌和贲门癌的细胞凋亡情况。结果:BE、食管腺癌和贲门癌组Ki-67阳性率分别为40.9%、69.6%和61.9%,均显著高于正常贲门组织(0.0%,P〈0.01)和贲门肠化生(IM)组(11.5%,P〈0.05)。BE、贲门IM、胃窦IM、食管腺癌和贲门癌组PCNA阳性率均显著高于正常贲门组织(45.5%、42.3%、39.3%、52.2%和42.9%对10.0%,P〈0.05)。BE、食管腺癌和贲门癌中Ki-67表达弱阳性和阳性者细胞凋亡指数均较表达阴性者显著降低(P〈0.05),而PCNA仅表达阳性者凋亡指数较表达阴性者显著降低(P〈0.05)。结论:BE和EGJ处肿瘤的发生与Ki-67表达异常有关,Ki-67较PCNA更能反映EGJ处细胞凋亡状态。

关 键 词:食管胃接合处  Barrett食管  Ki-67抗原  增殖细胞核抗原  细胞凋亡  组织微阵列

Investigation of Ki-67 Expression in Esophagogastric Mucosal Lesions and its Relationship with Cell Proliferation and Apoptosis by Tissue Microarray
CHANG Ying,LIU Guisheng,GONG Jun,ZHANG Jun. Investigation of Ki-67 Expression in Esophagogastric Mucosal Lesions and its Relationship with Cell Proliferation and Apoptosis by Tissue Microarray[J]. Chinese Journal of Gastroenterology, 2009, 14(2): 103-106
Authors:CHANG Ying  LIU Guisheng  GONG Jun  ZHANG Jun
Affiliation:. (Digestive Endoscopy Center, Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai (200233))
Abstract:Background: The incidence of esophageal and esophagogastric junction (EGJ) adenocarcinomas is increasing over the last two decades. Barrett's esophagus (BE) is thought to be a premalignant condition of esophageal adenocarcinoma and most of adenocarcinomas at EGJ. Aims: To investigate the expression of Ki-67 in esophagogastric mucosal lesions and its relationship with cell proliferation and apoptosis by tissue microarray. Methods: Using tissue microarray technique, specimens of 140 various esophagogastric mucosal tissues were examined for Ki-67 and proliferating cell nuclear antigen (PCNA) expressions by immunohistochemical method. Cell apoptosis in BE as well as in esophageal and cardiac adenocarcinoma was determined by in situ end-labeling technique (TUNEL method). Results: The positivity rate of Ki-67 in BE, esophageal adenocarcinoma and cardiac adenocarcinoma was 40.9%, 69.6% and 61.9%, respectively, which was significantly higher than that in normal cardiac tissue (0.0%, P〈0.01) and cardiac intestinal metaplasia (IM) tissue (11.5%, P〈0.05). The positivity rate of PCNA in BE, cardiac IM, antral IM, esophageal adenocarcinoma and cardiac adenocarcinoma was 45.5%, 42.3%, 39.3%, 52.2% and 42.9%, respectively, which was significantly higher than that in normal cardiac tissue (10.0%, P〈0.05). In BE, esophageal adenocarcinoma and cardiac adenocarcinoma, the cell apoptotic index in Ki-67 weakly positive and positive tissues was significantly lower than that in Ki-67 negative tissue (P〈0.05); while the apoptotic index only in PCNA positive tissue was significantly lower than that in PCNA negative tissue (P〈0.05). Conclusions: Abberant Ki-67 expression is involved in the development of BE and adenocarcinoma in EGJ. As compared with PCNA, Ki-67 is a more preferable marker reflecting apoptotic status in EGJ.
Keywords:Esophagogastric Junction  Barrett Esophagus  Ki-67 Antigen  Proliferating Cell Nuclear Antigen  Apoptosis  Tissue Microarray
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号